Ambuja Cements (AMBUJACEM) — Board Meeting

Ambuja Cements received NSE's no-objection letter on July 17, 2025 for its proposed amalgamation with Sanghi Industries Limited under the Companies Act, 2013. The scheme, originally approved by Ambuja's board in December 2024, now proceeds toward NCLT filing. NSE conditionally approved the merger subject to compliance with 16 detailed regulatory requirements, including disclosure of pending litigation, shareholder valuations, financial details from the past 3 years, and NOCs from lenders. The observation letter remains valid for 6 months from July 1, 2025, and all new information must be disclosed on company websites.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this board meeting affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 17 July 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 17 July 2025

TECHM Tech Mahindra Limited Financial Results WIPRO Wipro Limited Financial Results WIPRO Wipro Limited Corporate Action WIPRO Wipro Limited Corporate Action WIPRO Wipro Limited Financial Results AXISBANK Axis Bank Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.